Clinical Trial Update: Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of capecitabine and gemcitabine in metastatic colorectal/colon cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Southern California | Conditions: Colorectal Cancer, Colon Cancer | Phase 2 | Status: COMPLETED